908 Devices (MASS) Fundamentals 2026 — Revenue Analysis | SniperIQ
908 Devices (MASS) is a US-listed Healthcare company in Medical - Specialties with a market capitalization of
908 Devices (MASS) has a market capitalization of approximately
908 Devices's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
908 Devices runs a net profit margin of -62.1%, a gross margin of 49.0%, and an operating margin of -52.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
908 Devices reported revenue of $56M for fiscal year 2025, with net income of -
908 Devices does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
908 Devices carries a debt-to-equity ratio of 0.03x and a current ratio of 3.58x, with a market beta of 0.63. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For 908 Devices (MASS) the key facts are: market cap
Get 908 Devices's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.